Popular New
- Anticipating outcomes for patients with COVID-19 and identifying prognosis patterns4 daysLancet Infectious DiseasesRead
- Scaling up COVID-19 rapid antigen tests: promises and challenges4 daysLancet Infectious DiseasesRead
- Correction to Lancet Infect Dis 2021; published online Jan 21. https://doi.org/10.1016/S1473-3099(20)30942-74 daysLancet Infectious DiseasesRead
- Correction to Lancet Infect Dis 2020; published online Feb 16. https://doi.org/10.1016/S1473-3099(20)30784-24 daysLancet Infectious DiseasesRead
- Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study4 daysLancet Infectious DiseasesRead
- Importance of non-pharmaceutical interventions in lowering the viral inoculum to reduce susceptibility to infection by SARS-CoV-2 and potentially disease severity5 daysLancet Infectious DiseasesRead
- What does 95% COVID-19 vaccine efficacy really mean?10 daysLancet Infectious DiseasesRead
- BCG: new life for a centenarian vaccine10 daysLancet Infectious DiseasesRead
- BCG-induced non-specific effects on heterologous infectious disease in Ugandan neonates: an investigator-blind randomised controlled trial10 daysLancet Infectious DiseasesRead
- Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Micro11 daysLancet Infectious DiseasesRead
- Anti-SARS-CoV-2 antibodies in healthy donor plasma pools and IVIG products11 daysLancet Infectious DiseasesRead
- Correction to Lancet Infect Dis 2021; online Feb 3. https://doi.org/10.1016/S1473-3099(21)00043-811 daysLancet Infectious DiseasesRead
- Correction to Lancet Infect Dis 2021; published online Jan 20. https://doi.org/10.1016/S1473-3099(20)30990-711 daysLancet Infectious DiseasesRead
- Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran – Authors' reply11 daysLancet Infectious DiseasesRead
- Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran11 daysLancet Infectious DiseasesRead
- Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran11 daysLancet Infectious DiseasesRead
- Cardiac safety of multidrug-resistant tuberculosis treatment: moving towards individualised monitoring15 daysLancet Infectious DiseasesRead
- Genomic-informed pathogen surveillance in Africa: opportunities and challenges15 daysLancet Infectious DiseasesRead
- QT effects of bedaquiline, delamanid, or both in patients with rifampicin-resistant tuberculosis: a phase 2, open-label, randomised, controlled trial15 daysLancet Infectious DiseasesRead
- The COVID-19 exit strategy—why we need to aim low16 daysLancet Infectious DiseasesRead
- Correction to Lancet Infect Dis 2020; 20: 1263–7216 daysLancet Infectious DiseasesRead
- Prevention of influenza during mismatched seasons in older adults with an MF59-adjuvanted quadrivalent influenza vaccine: a randomised, controlled, multicentre, phase 3 efficacy study18 daysLancet Infectious DiseasesRead
- Cross-protective potential of a MF59-adjuvanted quadrivalent influenza vaccine in older adults18 daysLancet Infectious DiseasesRead
- Correction to Lancet Infect Dis 2020; published online Dec 8. https://doi.org/10.1016/S1473-3099(20)30927-019 daysLancet Infectious DiseasesRead
- CovMT: an interactive SARS-CoV-2 mutation tracker, with a focus on critical variants19 daysLancet Infectious DiseasesRead
- Correction to Lancet Infect Dis 2021; published online Jan 29. https://doi.org/10.1016/S1473-3099(20)30692-722 daysLancet Infectious DiseasesRead
- Long COVID: tackling a multifaceted condition requires a multidisciplinary approach24 daysLancet Infectious DiseasesRead
- In favour of a bespoke COVID-19 vaccines compensation scheme24 daysLancet Infectious DiseasesRead
- Inactivated COVID-19 vaccines to make a global impact24 daysLancet Infectious DiseasesRead
- Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial24 daysLancet Infectious DiseasesRead
- Understanding the drivers of transmission of SARS-CoV-225 daysLancet Infectious DiseasesRead
- Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study25 daysLancet Infectious DiseasesRead
- Immunogenicity and persistence of trivalent measles, mumps, and rubella vaccines: a systematic review and meta-analysis25 daysLancet Infectious DiseasesRead
- Has the bubble burst for transcriptomics in tuberculosis diagnosis?33 daysLancet Infectious DiseasesRead
- Regulatory approval of COVID-19 vaccine for restricted use in clinical trial mode33 daysLancet Infectious DiseasesRead
- Transcriptomic signatures have a place in short-term prediction of incident tuberculosis33 daysLancet Infectious DiseasesRead
- Transcriptomic signatures for diagnosing tuberculosis in clinical practice: a prospective, multicentre cohort study33 daysLancet Infectious DiseasesRead
- Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial33 daysLancet Infectious DiseasesRead
- Correction to Lancet Infect Dis 2020; 20: 1263–7236 daysLancet Infectious DiseasesRead
- Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial37 daysLancet Infectious DiseasesRead
- Immunity against diphtheria among children aged 5–17 years in India, 2017–18: a cross-sectional, population-based serosurvey37 daysLancet Infectious DiseasesRead
- Optimism and caution for an inactivated COVID-19 vaccine37 daysLancet Infectious DiseasesRead
- Structured serological testing is an essential component to investigating SARS-CoV-2 reinfection38 daysLancet Infectious DiseasesRead
- Factors associated with progression to death in patients with Lassa fever in Nigeria: an observational study38 daysLancet Infectious DiseasesRead
- Strange Bedfellows: Adventures in the Science, History, and Surprising Secrets of STDs, Ina Park. Flatiron Books (2020), 320, Written by US$27·99, ISBN: 978-125020662639 daysLancet Infectious DiseasesRead
- COVID-19 through the Latinx infectious disease doctor's eyes39 daysLancet Infectious DiseasesRead
- Meningococcal carriage in periods of high and low invasive meningococcal disease incidence in the UK: comparison of UKMenCar1–4 cross-sectional survey results39 daysLancet Infectious DiseasesRead
- Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study40 daysLancet Infectious DiseasesRead
- Long COVID in the skin: a registry analysis of COVID-19 dermatological duration41 daysLancet Infectious DiseasesRead
- An exceptional vaccination policy in exceptional circumstances41 daysLancet Infectious DiseasesRead
Quick Link
- Medicine - All Feeds
- Allergology and Immunology
- Anatomy and Physiology
- Anesthesiology and Intensive Care
- Biochemistry
- Bioengineering
- Biophysics
- Biotechnology
- Cardiology
- Cardiothoracic Surgery
- Clinical Chemistry
- Clinical Medicine
- Complementary Medicine
- Cytology and Histology
- Dentistry
- Dermatology
- Endocrinology
- Forensic Medicine
- Gastroenterology
- General Practice
- Genetics
- Geriatrics
- Health services and Administration
- Hematology
- Infectious Diseases
- Internal Medicine
- Logopedics
- Medical Education and Humanities
- Medical Microbiology
- Medicine - Other
- Nephrology
- Neurology
- Neurosurgery
- Nursing
- Nutritional Sciences
- Obstetrics and Gynecology
- Occupational Health
- Oncology
- Ophthalmology
- Oral and Maxillofacial Surgery
- Orthopedics and Traumatology
- Otorhinolaryngology and Phoniatrics
- Pathology
- Pediatrics
- Pharmacology and Pharmacotherapy
- Physical and Rehabilitation Medicine
- Plastic Surgery
- Psychiatry
- Psychology
- Public Health
- Radiology
- Respiratory Medicine
- Rheumatology
- Sports Medicine
- Surgery
- Urology